Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)

    Funds for research to enhance recognition and eliminate HIV-1 infected cells by targeting cell surface HIV envelope for immunotherapies and vaccines.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000

    Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

    Study early immune system development from utero through childhood, focusing on HIV/ART exposure in neonates to adolescents, exploring immune cell mechanisms and systemic immunity.

    HHS-NIH11Due Feb 5, 2027$1,600,000

    Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV AIDS Research (U42 Clinical Trial Not Allowed)

    This grant funds development and integration of human-based research methods and supports high-quality animal models to advance HIV/AIDS research while reducing animal use where possible.

    HHS-NIH11Forecasted Jan 25, 2027$2,725,311Forecasted

    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

    This grant supports innovative research at the HIV and substance use intersection, focusing on new avenues for prevention, treatment, and cure among people who use drugs.

    HHS-NIH11Due Feb 3, 2027$9,000,000

    Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV

    This grant supports research to identify and validate new, modifiable therapeutic targets for improving central nervous system outcomes in people with HIV using patient data and innovative models.

    HHS-NIH11Due Oct 28, 2027